Literature DB >> 14977953

Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice.

Anna M van Heeckeren1, Mark Schluchter, Lintong Xue, Juan Alvarez, Steven Freedman, Judith St George, Pamela B Davis.   

Abstract

In cystic fibrosis, a recessive genetic disease caused by defects in the cystic fibrosis conductance regulator (CFTR), the main cause of death is lung infection and inflammation. Nutritional deficits have been proposed to contribute to the excessive host inflammatory response in both humans and Cftr-knockout mice. Cftr-knockout mice and gut-corrected Cftr-knockout mice expressing human CFTR primarily in the gut were challenged with Pseudomonas aeruginosa-laden agarose beads; they responded similarly with respect to bronchoalveolar lavage cell counts and levels of the acute-phase cytokines tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-6. Wild-type mice fed the liquid diet used to prevent intestinal obstruction in Cftr-knockout mice had inflammatory responses to P. aeruginosa-laden agarose beads similar to those of wild-type mice fed an enriched solid diet, so dietary effects are unlikely to account for differences between wild-type mice and mice with cystic fibrosis. Finally, since cystic fibrosis patients and Cftr-knockout mice have an imbalance in fatty acids (significantly lower-than-normal levels of docosahexaenoic acid), the effects of specific supplementation with docosahexaenoic acid of wild-type and Cftr-knockout mice on their inflammatory responses to P. aeruginosa-laden agarose beads were tested. There were no significant differences (P = 0.35) in cumulative survival rates between Cftr-knockout mice and wild-type mice provided with either the liquid diet Peptamen or Peptamen containing docosahexaenoic acid. In conclusion, diet and docosahexaenoic acid imbalances alone are unlikely to explain the differences in the host response to lung infections with mucoid P. aeruginosa between mice with cystic fibrosis and their wild-type counterparts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977953      PMCID: PMC356061          DOI: 10.1128/IAI.72.3.1479-1486.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

Review 2.  The mechanisms of action of PPARs.

Authors:  Joel Berger; David E Moller
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

3.  A rat model of chronic respiratory infection with Pseudomonas aeruginosa.

Authors:  H A Cash; D E Woods; B McCullough; W G Johanson; J A Bass
Journal:  Am Rev Respir Dis       Date:  1979-03

4.  Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis.

Authors:  M W Konstan; K M Vargo; P B Davis
Journal:  Am Rev Respir Dis       Date:  1990-01

5.  Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.

Authors:  Anna M Van Heeckeren; Abraham Scaria; Mark D Schluchter; Thomas W Ferkol; Samuel Wadsworth; Pamela B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-09-26       Impact factor: 5.464

6.  Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis.

Authors:  Michael W Konstan; Steven M Butler; Mary Ellen B Wohl; Marcia Stoddard; Robert Matousek; Jeffrey S Wagener; Charles A Johnson; Wayne J Morgan
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

7.  Murine models of chronic Pseudomonas aeruginosa lung infection.

Authors:  Anna M van Heeckeren; M D Schluchter
Journal:  Lab Anim       Date:  2002-07       Impact factor: 2.471

Review 8.  Prostaglandins, arachidonic acid, and inflammation.

Authors:  F A Kuehl; R W Egan
Journal:  Science       Date:  1980-11-28       Impact factor: 47.728

9.  A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia.

Authors:  J R Starke; M S Edwards; C Langston; C J Baker
Journal:  Pediatr Res       Date:  1987-12       Impact factor: 3.756

Review 10.  The pancreas in cystic fibrosis.

Authors:  C J Taylor; N Aswani
Journal:  Paediatr Respir Rev       Date:  2002-03       Impact factor: 2.726

View more
  7 in total

1.  Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.

Authors:  Anna M van Heeckeren; Mark D Schluchter; Wei Xue; Pamela B Davis
Journal:  Am J Respir Crit Care Med       Date:  2005-11-04       Impact factor: 21.405

2.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

3.  Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.

Authors:  Oxana Norkina; Tim G Burnett; Robert C De Lisle
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.

Authors:  Chirag Kariya; Heather Leitner; Elysia Min; Christiaan van Heeckeren; Anna van Heeckeren; Brian J Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-16       Impact factor: 5.464

5.  Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.

Authors:  Rachida Legssyer; François Huaux; Jean Lebacq; Monique Delos; Etienne Marbaix; Patrick Lebecque; Dominique Lison; Bob J Scholte; Pierre Wallemacq; Teresinha Leal
Journal:  Respir Res       Date:  2006-10-25

6.  Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.

Authors:  Jennifer Palomo; Tiffany Marchiol; Julie Piotet; Louis Fauconnier; Marieke Robinet; Flora Reverchon; Marc Le Bert; Dieudonnée Togbe; Ruvalic Buijs-Offerman; Marta Stolarczyk; Valérie F J Quesniaux; Bob J Scholte; Bernhard Ryffel
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  HDAC6 depletion improves cystic fibrosis mouse airway responses to bacterial challenge.

Authors:  Julie Rosenjack; Craig A Hodges; Rebecca J Darrah; Thomas J Kelley
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.